Permanently Discontinued

IBSRELA

KNIGHT THERAPEUTICS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is IBSRELA discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that IBSRELA 50MG has been permanently discontinued (last updated March 18, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength50MG

Last updated2026-03-18

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02498049

Strength

50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

TENAPANOR

See all TENAPANOR products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-03-18

Anticipated Shortage

Other (Please describe in comments)

Other Products from KNIGHT THERAPEUTICS INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AKYNZEO

DIN 02468735

ALOXI

0.5MG · DIN 02381729

ALOXI

0.25MG · DIN 02381710

ANACIN

DIN 02332450

ANTIZOL

1G · DIN 02242980

BIJUVA

DIN 02505223